A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide

Glioblastoma is the most malignant brain tumor, exhibiting remarkable resistance to treatment. Here we investigated the oncogenic potential of HOXA9 in gliomagenesis, the molecular and cellular mechanisms by which HOXA9 renders glioblastoma more aggressive, and how HOXA9 affects response to chemothe...

Full description

Bibliographic Details
Main Author: Pojo, M (author)
Other Authors: Gonçalves, CS (author), Xavier-Magalhães, A (author), Oliveira, AI (author), Gonçalves, T (author), Correia, S (author), Rodrigues, AJ (author), Costa, S (author), Pinto, L (author), Pinto, AA (author), Lopes, JM (author), Reis, RM (author), Rocha, M (author), Sousa, N (author), Costa, BM (author)
Format: article
Language:eng
Published: 2015
Subjects:
Glioblastoma
Online Access:http://hdl.handle.net/10400.23/841
Country:Portugal
Oai:oai:repositorio.hospitaldebraga.pt:10400.23/841

Internet

http://hdl.handle.net/10400.23/841

Similar Items